Agent for removing senescent cells and agent for suppressing decrease in motor function

HK40137543APending Publication Date: 2026-09-11EZAKI GLICO CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026127171
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-17
Filing Date
2026-08-06
Publication Date
2026-09-11

Smart Images

  • Figure 00000023_0000
    Figure 00000023_0000
  • Figure 00000023_0001
    Figure 00000023_0001
  • Figure 00000024_0000
    Figure 00000024_0000
Patent Text Reader

Abstract

An object of the present application is to provide a preparation and a composition which can be ingested in the field of food and beverages and is effective for removing senescent cells. The present application provides a senescent cell removing agent containing an effective amount of at least one selected from the group consisting of acacia flower, acacia bark, and extracts thereof.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480082102.4 (22) Application Date 2024.12.25 (30) Priority Data 2023-217850 2023.12.25 JP 2024-182207 2024.10.17 JP (85) PCT International Application Entering National Phase Date 2026.06.24 (86) PCT International Application Application Data PCT / JP2024 / 045803 2024.12.25 (87) PCT International Application Publication Data WO2025 / 142973 JA 2025.07.03 (71) Applicant: Ezaki Glico Co., Ltd. Address: Osaka Prefecture, Japan (72) Inventors: Nagano Taiki, Kajiura Hideki, Kimura Motoko, Yamamoto Muneto, Mura Tomohiko, Ujiya Rinako (74) Patent Agency: Longtian Intellectual Property Agency Co., Ltd. 72003 Patent Attorney: Chen Xi (51) Int.Cl. A23L 33 / 105 (2006.01) A23L 33 / 10 (2006.01) A61K 8 / 9789 (2006.01) A61K 36 / 48 (2006.01) A61P 43 / 00 (2006.01) A61Q 1 / 00 ​​(2006.01) A61Q 19 / 08 (2006.01) A61K 129 / 00 (2006.01) A61K 133 / 00 (2006.01) (54) Invention Title: Senescent Cell Removal Agent and Motor Function Reduction Inhibitor (57) Abstract: The object of this invention is to provide formulations and compositions that are effective in removing senescent cells and can be ingested in the food and beverage industry. This invention provides a senescent cell removal agent containing an effective amount of at least one selected from the group consisting of Albizia julibrissin flower, Albizia julibrissin bark, and extracts thereof. Claims: 1 page Description: 10 pages Drawings: 2 pages CN 122476965 A 2026.07.28 CN 1 22 47 69 65 A 1. A senescent cell removal agent, wherein the senescent cell removal agent contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flower, Albizia julibrissin bark, and extracts thereof. 2. The senescent cell removal agent according to claim 1, wherein the senescent cell removal agent is labeled with at least one of the following: “reducing senescent cells”, “removing senescent cells”, “reducing the proportion of senescent cells”, “promoting the reduction of senescent cells”, and “inhibiting motor function reduction”. 3. The senescent cell removal agent according to claim 1, characterized in that,The removal of senescent cells is the selective removal of senescent cells relative to normal cells. 4. The senescent cell removal agent according to claim 1, characterized in that the ratio of the 50% lethal concentration LC50 (A) in normal cells to the 50% lethal concentration (B) in senescent cells (A / B) exceeds 1.1. 5. The senescent cell removal agent according to claim 1, wherein the senescent cell removal agent is a food, cosmetic, or pharmaceutical. 6. An inhibitor of decreased motor function, wherein the inhibitor of decreased motor function contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof. Claims 1 / 1 page 2 CN 122476965 A Senescent Cell Removal Agent and Inhibitor of Decreased Motor Function Technical Field

[0001] The present invention relates to senescent cell removal agents. More specifically, the present invention relates to senescent cell removal agents, characterized in that they selectively remove senescent cells relative to normal cells. Background Art

[0002] Currently, developed countries are becoming aging societies, and average life expectancy is increasing, but the gap with healthy life expectancy has become a problem. Healthy lifespan is a health indicator advocated by the WHO (World Health Organization), referring to the period during which individuals are physically and mentally independent and able to live healthily. The gap between healthy lifespan and average lifespan, which is the "unhealthy period" with limited daily life, is said to be about 9 years for Japanese men and about 12 years for Japanese women.

[0003] From the perspective of addressing a super-aged society, research and development of technologies to extend healthy lifespan are underway, and cellular senescence and the removal of senescent cells are receiving much attention. Senescent cells are cells whose cell division has irreversibly stopped, and they exist not only in the elderly but also in young people and newborns.

[0004] It is becoming increasingly clear that DNA damage caused by stresses such as ultraviolet radiation and reactive oxygen species, as well as telomere shortening, can induce cellular senescence. Since it is also implied that inflammatory proteins secreted by senescent cells may cause various diseases, there is a strong demand for cellular senescence control technologies to inhibit the induction of senescent cells and remove the resulting senescent cells.

[0005] For example, Patent Document 1 reports that sodium-glucose co-transporter 2 (SGLT2) inhibitors have a senescent cell removal effect. Specifically,Canagliflozin, an SGLT2 inhibitor, has been confirmed to remove senescent cells in obese mouse models, atherosclerotic mouse models, and progeria mouse models.

[0006] Prior Art Documents

[0007] Patent Documents

[0008] Patent Document 1: Japanese Patent Application Publication No. 2022-101541; Patent Document 2: Japanese Patent Application Publication No. 2010-235548. Summary of the Invention

[0009] Problems to be Solved by the Invention

[0010] However, removing the generated senescent cells is difficult in itself, and in particular, techniques capable of selectively removing senescent cells are almost non-existent. In addition, there are currently no sufficient reports on ingredients that are effective in removing senescent cells, which can be obtained from plant resources and are also available in the food and beverage industry.

[0011] Therefore, the object of the present invention is to provide formulations and compositions that are effective in removing senescent cells and can also be obtained from the food and beverage industry.

[0012] Means for solving the problem

[0013] In order to solve the above-mentioned problem, the inventors conducted in-depth research and found that Albizia julibrissin, which has been used in the food industry, has the effect of removing senescent cells, thus completing the present invention. In addition, the inventors also found that Albizia julibrissin has the effect of inhibiting the decline of motor function.

[0014] That is, the present invention provides the preparations and compositions listed below. Specification 1 / 10 pages 3 CN 122476965 A

[0015] Item 1. A senescent cell removal agent, wherein the senescent cell removal agent contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark and extracts thereof.

[0016] Item 2. The senescent cell removal agent according to item 1, wherein the senescent cell removal agent is labeled with at least one of the following: "reducing senescent cells", "removing senescent cells", "reducing the proportion of senescent cells", "promoting the reduction of senescent cells" and "inhibiting the decline of motor function".

[0017] Item 3. The senescent cell removal agent according to Item 1 or Item 2, characterized in that the senescent cell removal is a selective removal of senescent cells relative to normal cells.

[0018] Item 4. The senescent cell removal agent according to any one of Items 1 to 3, characterized in that the ratio (A) of the 50% lethal concentration (LC50) in normal cells to the 50% lethal concentration in senescent cells (A / B) exceeds 1.1.

[0019] Item 5. The senescent cell removal agent according to any one of Items 1 to 4, wherein the senescent cell removal agent is a food, cosmetic, or pharmaceutical.

[0020] Item 6. An inhibitor of decreased motor function, wherein...The motor function reduction inhibitor contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof.

[0021] Item 7. A food composition containing an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof, for reducing senescent cells, removing senescent cells, reducing the proportion of senescent cells, promoting the reduction of senescent cells, or inhibiting motor function reduction.

[0022] Item 8. The application of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof, for manufacturing a composition for reducing senescent cells, removing senescent cells, reducing the proportion of senescent cells, promoting the reduction of senescent cells, or inhibiting motor function reduction.

[0023] Item 9. The application of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof according to Item 8, wherein the composition is a composition for use in food, cosmetics, or pharmaceuticals.

[0024] It should be noted that in the aforementioned Patent Document 2, neither the ability to remove senescent cells produced by Albizia julibrissin is disclosed nor implied.

[0025] Effects of the Invention

[0026] According to the present invention, by using Albizia julibrissin, which can be ingested in the food and beverage industry, senescent cells can be effectively removed. Furthermore, by using Albizia julibrissin, the decline in motor function can be inhibited. Brief Description of the Drawings

[0027] Figure 1 is a graph showing the results of the senescent cell removal ability in Test Example 1.

[0028] Figure 2 is a graph showing the results of the motor function confirmation test of the control group and the Albizia julibrissin flower extract group (0.1 mg / mL) in Test Example 2.

[0029] Figure 3 is a graph showing the results of the motor function confirmation test of the control group and the Albizia julibrissin bark extract group (0.01 mg / mL) in Test Example 2. Detailed Description of the Invention

[0030] [Senescent Cell Removal Agent]

[0031] In one embodiment, the senescent cell removal agent of the present invention contains Albizia julibrissin.

[0032] (Albizia julibrissin)

[0033] Albizia is a deciduous tree belonging to the subfamily Mimosoideae of the Fabaceae family. Albizia is also known as the mimosa tree, and its name comes from the dormant movement of its leaflets closing and drooping at night.

[0034] In addition to being distributed in Honshu, Shikoku, Kyushu, and other parts of Japan, Albizia also grows wild in Iran, Afghanistan, China, the Korean Peninsula, and other places, so it can be easily obtained from these regions.

[0035] In addition to sun-drying the flowers and bark for use as raw medicine, Albizia is also used to improve stress, etc., by decocting and drinking the decoction.

[0036] There are no particular restrictions on the parts of Albizia used; the whole plant can be used.It can also be leaves, fruits, flowers, branches, trunks, roots, seeds, or a mixture of at least two or more of them. In one embodiment, the part of Albizia julibrissin used preferably includes flowers and / or bark, more preferably flowers and bark.

[0037] Albizia julibrissin can be used directly in its fresh state, or it can be used as a dried product (e.g., freeze-dried). In the case of extraction from Albizia julibrissin, from the viewpoint of improving extraction efficiency, it can be used, for example, after being processed into a crushed or powdered state.

[0038] Albizia julibrissin can be used, for example, as a flaky, powdered, granular, or paste-like crushed or pulverized product, among which powder is preferred.

[0039] The method for processing into crushed or pulverized products can use known methods without particular limitation, for example: processing of plant body to crush or pulverize using equipment or appliances such as crushers, mills, mixers, blenders, and stone mills by any method commonly used by those skilled in the art.

[0040] The plant body can be dried before crushing or pulverizing. As a drying process, known methods can be used without particular limitations, such as freeze drying, vacuum drying, air drying, or heat drying.

[0041] When using extracts of Albizia julibrissin, the method is not particularly limited, and extraction can be performed using conventional extraction methods for plant materials. As an extraction method, although there are no limitations, examples include solvent extraction, steam distillation, pressing (direct, high temperature, or low temperature), or supercritical extraction. In addition, combinations of these extraction methods are also possible, such as solvent extraction after crushing.

[0042] The extraction solvent is not particularly limited as long as it is a conventional solvent used for extracting plant materials. For example, organic solvents, aqueous solvents, or mixtures of organic and aqueous solvents can be used as extraction solvents, but aqueous solvents or mixtures of organic and aqueous solvents are preferred, and aqueous solvents are more preferred.

[0043] Examples of organic solvents include alcohols, acetone, benzene, esters, ethyl acetate, hexane, chloroform, or diethyl ether, but alcohols are preferred. As for alcohols, there are no particular limitations as long as they are common solvents used for the extraction of plant raw materials. Examples include monohydric alcohols with 1 to 5 carbon atoms such as ethanol, methanol, propanol, isopropanol, and butanol; and polyhydric alcohols with 2 to 5 carbon atoms such as 1,3-butanediol, propylene glycol, dipropylene glycol, and glycerol.

[0044] As for aqueous solvents, there are no particular limitations as long as they contain water. Examples include water, physiological saline, or buffer solutions. Examples of buffer solutions include phosphate buffer, sodium phosphate buffer, sodium carbonate buffer, citrate buffer, citrate-phosphate buffer, acetate buffer, and Tris buffer. Preferred aqueous solvents are water and / or physiological saline. The pH of the aqueous solvent is not particularly limited.

[0045] Among these extraction solvents, from the viewpoint of significantly exerting the effects of the present invention,Preferably, it is selected from at least one of the group consisting of water, ethanol, 1,3-butanediol and propylene glycol, more preferably water and / or ethanol, and even more preferably water or aqueous ethanol.

[0046] As an extraction solvent, when using a mixture of organic solvent and aqueous solvent, the content of aqueous solvent in the total amount of extraction solvent is not particularly limited, for example: 30% by mass or more, 40% by mass or more, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, or 90% by mass or more, 95% by mass or more, etc. Specification 3 / 10 page 5 CN 122476965 A

[0047] The extraction temperature is not particularly limited, for example: -50℃~150℃, 0℃~100℃, 5℃~95℃, 10℃~95℃, 15℃~95℃, 30℃~90℃, 50℃~90℃, 70℃~90℃, 80℃~90℃, etc.

[0048] During extraction, from the viewpoint of improving extraction efficiency, it is preferable to perform the extraction while stirring or shaking, for example. The extraction time can be appropriately determined, for example, depending on the part used, such as leaves, fruits, flowers, branches, trunks, roots, seeds, etc. In addition, the extraction time can be appropriately determined according to the state of Albizia julibrissin, i.e., fresh or dried, or broken or pulverized, or their processing state. The extraction time is usually 1 minute to 72 hours, preferably 10 minutes to 48 hours, and most preferably 30 minutes to 2 hours.

[0049] As an example, the extract of Albizia julibrissin refers to an extract obtained by macerating and extracting Albizia julibrissin flowers and / or bark or their pulverized parts with water and / or organic solvents and filtering and separating the residue; an extract obtained by removing the solvent from the extract; or their fine powder; or an extract obtained by dissolving, dispersing, or diluting the above-mentioned extract or solvent-removed parts with a suitable solvent, etc., and commercially available products can also be used. As an example of other extraction methods, the extract of Albizia julibrissin can also be extracted after processing such as steaming the flowers and / or bark of Albizia julibrissin. Alternatively, the leaves and branches accompanying the flowers and / or bark of the Albizia julibrissin may be removed, or they may be used directly without removal.

[0050] The content of the Albizia julibrissin plant or its extract can be appropriately adjusted according to the type or amount of other ingredients, dosage form, etc., without limitation, but relative to the total amount of the composition, it can be set to 0.01% by mass or more, or 0.05% by mass or more, 0.1% by mass or more, 0.5% by mass or more, 1% by mass or more, 10% by mass or more, 20% by mass or more, 30% by mass or more, 40% by mass or more, 50% by mass or more, 60% by mass or more, 70% by mass or more, etc., for example, relative to the total amount of the composition. In addition, relative to the total amount of the composition, the content of the Albizia julibrissin plant or its extract can be set to 100% by mass or less, for example.Examples include: below 90% mass, below 80% mass, below 70% mass, below 60% mass, below 50% mass, below 40% mass, below 30% mass, below 20% mass, below 10% mass, etc. In addition, relative to the total amount of the composition, the content of Albizia julibrissin plant material or its extract can be listed as follows: 0.01–100% by mass, 0.1–100% by mass, 1–100% by mass, 5–100% by mass, 10–100% by mass, 20–100% by mass, 30–100% by mass, 40–100% by mass, 50–100% by mass, 0.01–90% by mass, 0.1–90% by mass, 1–90% by mass, 5–90% by mass, 10–90% by mass, 20–90% by mass, 30–90% by mass, 40–90% by mass, 50–90% by mass, 0.01–80% by mass, 0.1–80% by mass, 1–80% by mass, 5–80% by mass, 10–80% by mass, 20–80% by mass. % by mass, 30-80% by mass, 40-80% by mass, 50-80% by mass, 0.01-70% by mass, 0.1-70% by mass, 1-70% by mass, 5-70% by mass, 10-70% by mass, 20-70% by mass, 30-70% by mass, 40-70% by mass, 50-70% by mass, 0.01-60% by mass, 0.1-60% by mass, 1-60% by mass, 5-60% by mass, 10-60% by mass, 20-60% by mass, 30-60% by mass, 40-60% by mass, 0.01-50% by mass, 0.1-50% by mass, 1-50% by mass, 5-50% by mass, 10-50% by mass, 20-50% by mass, 30-50% by mass, 0.01-40% by mass, 0.1-40% by mass, 1-40% by mass, 5-40% by mass 10-40% by mass, 20-40% by mass, 0.01-30% by mass, 0.1-30% by mass, 1-30% by mass, 5-30% by mass, 10-30% by mass, 0.01-20% by mass, 0.1-20% by mass, 1-20% by mass, 5-20% by mass, etc.

[0051] [Uses]

[0052] The senescent cell removal agent of the present invention effectively removes senescent cells, and is preferably suitably used to selectively remove senescent cells relative to normal cells. In this specification, senescent cells refer to cells that have lost the proliferative capacity brought about by cell division. Becoming senescent cells is sometimes referred to as a defense mechanism that stops cell division and prevents carcinogenesis when DNA suffers irreparable damage due to stress such as ultraviolet radiation. However, it is known that if senescent cells are not eliminated and continue to remain in the body, they will secrete inflammatory proteins, etc., causing chronic inflammation. In addition, in this specification,Normal cells that can be compared with senescent cells are those that have not lost their proliferative capacity due to cell division.

[0053] Senescent cells are identified by markers of increased p16 gene and β-galactosidase activity, and it is gradually becoming clear in the specification 4 / 10 pages 6 CN 122476965 A that age-related changes can be suppressed by removing senescent cells from individuals who are aging. For example, in non-alcoholic steatohepatitis (NASH), there is a situation where inflammation is caused by the accumulation of senescent cells, but it has been reported that removing senescent cells helps to improve inflammation.

[0054] Even though there are anti-inflammatory components for symptomatic treatment of inflammation caused by the accumulation of senescent cells, simply suppressing inflammation is not a fundamental solution as long as senescent cells accumulate. In addition, various components are being screened with the goal of anti-aging, but there are insufficient reports on components that can inhibit the generation of senescent cells. Furthermore, there are almost no reports on techniques for distinguishing senescent cells that have been generated and accumulated from normal cells and selectively removing only senescent cells.

[0055] The accumulation of senescent cells does not necessarily occur only in the elderly and patients, but also in young people and newborns. Therefore, the goal is not to solve this problem with drugs, but to find a technology that can selectively remove senescent cells using everyday ingestible ingredients. However, there are almost no research reports based on this viewpoint.

[0056] In the examples (experimental examples) described later, after obtaining senescent cells by acting etoposide, a cell senescence inducer, on HepG2 cells from human liver cancer, the effect of at least one selected from the group consisting of Albizia julibrissin flower, Albizia julibrissin bark, and their extracts was confirmed, together with quercetin, which is known to have the ability to remove senescent cells.

[0057] As a result, a significant ability to selectively remove senescent cells was confirmed in at least one selected from the group consisting of Albizia julibrissin flower, Albizia julibrissin bark, and their extracts, compared with quercetin.

[0058] Therefore, at least one selected from the group consisting of Albizia julibrissin flower, Albizia julibrissin bark, and their extracts can also be applied to selective senescent cell removers that can effectively remove senescent cells, preferably selectively remove senescent cells relative to normal cells.

[0059] As described in the embodiments below, the ability to selectively remove senescent cells relative to normal cells (senescent cell removal capacity) can be calculated by determining the ratio (A / B) of the 50% lethal concentration in (A) normal cells to the 50% lethal concentration in (B) senescent cells. The senescent cell removal capacity is not limited as long as the effects of the present invention are achieved; for example, this ratio (A / B) is preferably greater than 1.1.It can also be 1.2 or higher, 1.5 or higher, 2 or higher, 2.5 or higher, 3 or higher, 3.5 or higher, 4 or higher, 4.5 or higher, 5 or higher, 5.5 or higher, 6 or higher, 7 or higher, 8 or higher, 9 or higher, etc.

[0060] [Motor Function Reduction Inhibitor]

[0061] In one embodiment, the motor function reduction inhibitor of the present invention contains Albizia julibrissin. The content described in the embodiments of the senescent cell removal agent also applies to this motor function reduction inhibitor.

[0062] The reduction of motor function is caused by various reasons such as lack of exercise and disease, and it also gradually progresses with age. The reduction of motor function carries the risk of causing states or symptoms such as sarcopenia, frailty, and locomotive syndrome. In addition, due to the reduction of muscle strength and balance function, the risk of falls and fractures increases. Furthermore, due to the lack of exercise caused by the reduction of motor function, there is also the risk of triggering or aggravating lifestyle-related diseases.

[0063] In the examples (experimental examples) described later, by comparing the control group without additives and the group with added Albizia julibrissin extract, the effect of at least one of the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and their extracts on inhibiting the reduction of motor function was confirmed.

[0064] The formulations and compositions of the present invention can be added to or mixed with food and beverages, cosmetics, pharmaceuticals, quasi-drugs, pet food, feed, etc. Alternatively, they can be used directly as pharmaceuticals, quasi-drugs, food and beverages, pet food, feed, etc. In addition, the formulations and compositions of the present invention can be used as food and beverages that explicitly or implicitly indicate the intention to remove senescent cells and inhibit the reduction of motor function, i.e., health foods, functionally labeled foods, patient instruction manuals, 5 / 10 pages 7 CN 122476965 A foods, and specific health foods. In addition, even without explicitly or implicitly indicating the above-mentioned functions, they can be used as so-called doctor-recommended supplements recommended or suggested by doctors in internal medicine, plastic surgery, veterinary hospitals, etc., in hospitals and / or clinics. When the aforementioned functionalities are explicitly stated, sometimes at least one label selected from the group consisting of "reducing senescent cells," "removing senescent cells," "reducing the proportion of senescent cells," "promoting the reduction of senescent cells," and "inhibiting decreased motor function" may be used, but this is not limited to these. Furthermore, as an effect produced by the aforementioned functionalities,Sometimes, the label may be selected from at least one of the following groups: “improving blood liver function enzyme levels,” “maintaining cognitive function,” “maintaining muscle strength,” “maintaining walking ability,” “maintaining the muscle mass, strength, and endurance required for independent daily living,” “maintaining agility,” “lowering fasting blood glucose levels,” “mitigating postprandial blood glucose rise,” “lowering blood triglycerides,” “maintaining the vascular flexibility that decreases with age,” “maintaining kidney filtration function,” “reducing temporary facial and leg swelling,” “reducing urination frequency,” “inhibiting orthostatic dizziness,” “maintaining bone health,” “maintaining bone density,” “reducing knee discomfort,” “assisting knee joint flexibility and mobility,” “improving skin hydration,” “maintaining skin elasticity,” “hair regeneration and growth,” “regulating gastrointestinal condition,” “improving visual function,” “reducing transient physical and mental fatigue,” “lowering biological age,” “improving sarcopenia,” “improving frailty,” “improving movement disorder syndrome,” “improving lifestyle-related diseases,” and “maintaining balance function,” but is not limited to these.

[0065] Without explicitly stating the above-mentioned functionality, the formulations and compositions of the present invention can be used under labels such as those for individuals concerned about senescent cells, those wishing to remove senescent cells, those wishing to inhibit or reduce senescent cells, those wishing to reduce the proportion of senescent cells, those concerned about liver or kidney function values, those experiencing muscle weakness, those concerned about blood sugar levels, those concerned about bone density, those experiencing knee discomfort, those concerned about skin condition, those concerned about gastrointestinal condition, those concerned about vision, those experiencing fatigue, and those concerned about walking speed.

[0066] There are no particular limitations on the dosage form of the formulations and compositions of the present invention, and examples include oral and non-oral preparations, but oral preparations are preferred. Examples of oral preparations include solid or powdered preparations such as granules, tablets, capsules, and pills, as well as liquid preparations such as suspensions, emulsions, syrups, and extracts. Examples of non-oral preparations include injections, topical preparations, and wet compresses.

[0067] The formulations and compositions of the present invention may consist of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof, or may contain at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof.

[0068] When the formulations and compositions of the present invention are oral dosage forms, they may contain other additives, such as: excipients, binders, disintegrants, emulsifiers, lubricants, flow promoters, diluents, preservatives, colorants, flavorings, taste enhancers, stabilizers, humectants, preservatives, antioxidants, or suspending agents, etc. Although there are no limitations, as additives,Examples include: gelatin, sodium alginate, starch, corn starch, white sugar, lactose, glucose, mannitol, carboxymethyl cellulose, dextrin, polyvinylpyrrolidone, crystalline cellulose, soybean lecithin, sucrose, fatty acid esters, talc, magnesium stearate, polyethylene glycol, magnesium silicate, silicic anhydride, or synthetic aluminum silicate, etc.

[0069] The formulations and compositions of the present invention can be administered to humans, but the subjects can also be animals other than humans, such as: pets such as dogs, cats, horses, miniature horses, donkeys, cattle, pigs, sheep, goats, rabbits, monkeys, hamsters, guinea pigs, mice, rats, ferrets, squirrels, and birds; livestock such as cattle, chickens, and pigs; and animals raised in pastures, zoos, etc. (horses, sheep, goats, monkeys, elephants, lions, cheetahs, etc.).

[0070] The compositions of the present invention can be food and beverages, cosmetics, pharmaceuticals, quasi-drugs, pet food, feed, etc.

[0071] The food and beverages include food and beverages. As food and beverages,For example, the following can be listed: beverages (soft drinks, instructions page 6 / 10, CN 122476965 A, ingredients (coffee, cocoa, fruit juice, mineral drinks, tea drinks (green tea, black tea, oolong tea), almond drinks, sports drinks, energy drinks, nutritional drinks, etc.), dairy drinks, lactic acid bacteria drinks, yogurt drinks, carbonated drinks, alcoholic beverages, spreads (custard, butter sauce, peanut butter, chocolate sauce, cheese sauce, etc.), pastes (fruit paste, vegetable paste, sesame paste, seaweed paste, etc.), Western pastries (chocolate, donuts, pies, muffins, waffles, chewing gum, gummy candy, jelly, candy, cookies, crackers, biscuits, snacks, cakes, puddings, etc.), Japanese pastries (maltose, senbei, hanrinto, rice crackers, dango, hagi mochi, daifuku mochi, bean mochi, etc.). Rice cakes, fillings, Japanese steamed buns, Nagasaki cakes, sweet bean paste, yokan (sweet bean jelly), frozen desserts (ice cream, popsicles, sorbet, etc.), soft-packaged foods (curry, stews, beef bowls, Chinese rice bowls, mixed porridge, thin porridge, miso soup, soup, meat sauce, savory sauce, meatballs, hamburger patties, oden, red bean rice, grilled chicken skewers, chawanmushi, etc.), ready-to-eat foods (instant ramen, instant vermicelli soup, instant tofu skin noodle soup, instant udon noodles, instant soba noodles, instant fried noodles, instant pasta, instant wonton noodles, instant red bean soup, miso soup base, powdered soup base, powdered fruit juice base, pancake mix, etc.), bottled / canned foods, jelly-like foods (jelly, agar, jelly-like beverages, etc.). Condiments (soy sauce, mirin, vinegar, miso, salad dressing, umami seasoning, compound seasoning, sauces, mayonnaise, ketchup, rice seasoning, tempura dipping sauce, noodle dipping sauce, broth base, Chinese soup base, clear meat broth, barbecue sauce, cold hot pot sauce, curry cubes, stew cubes, etc.), dairy products (milk, cheese, yogurt, butter, whipped cream, etc.), processed fruits (jam, orange marmalade, syrup-cured fruits, dried fruits, etc.), processed cereal products (noodles, pasta, bread, rice noodles, etc.), pickled vegetables (radish pickles, Nara pickles, kimchi, Fukujin pickles, pickled scallions, pickled cabbage, mustard seed pickles, shiitake pickles, asahi pickles, pickled cucumbers, etc.), pickling base (ready-to-eat pickling base, kimchi base, etc.), fish and meat products. (Fish cakes, chikuwa, half-sliced ​​fish cakes, etc.), meat products (ham, sausages, salami, bacon, etc.), delicacies (squid strips, cod strips, salted sea urchin, salted squid, salted octopus, mirin-flavored dried fish, mirin-flavored dried pufferfish, smoked squid, salted sea cucumber sausage, etc.), dried goods (seasoned seaweed, etc.), cooked dishes (cold dishes, fried dishes, stir-fries, barbecued dishes, stewed dishes, vinegared dishes, etc.), frozen foods (fried shrimp, croquettes, spring rolls, fried pork cutlets, shumai, dumplings, takoyaki, meat buns, red bean buns, etc.), baby food (e.g., rice and pasta dishes, fish dishes, meat dishes, egg dishes, dairy dishes, vegetable dishes, soups, fruits, juices, hydrating drinks, tea, desserts, snacks, sauces, rice seasonings, etc.); milk powder (e.g.,Regular formula milk powder, special formula milk powder, milk powder for pregnant and lactating women, etc.); enteral nutrition foods (e.g., enteral nutrition agents, thick liquid foods, nutritional supplements, nutritional aids, flavorings for enteral nutrition agents and thick liquid foods, desserts, etc.); other foods (e.g., nutritional aids, stirred foods, thickened foods, foods for examination, cereal foods, sports foods, emergency foods, etc.).

[0072] Although there are no restrictions on these foods or beverages, they may contain, for example, antioxidants, flavorings, acidulants, colorings, emulsifiers, preservatives, seasonings, sweeteners, spices, pH adjusters, stabilizers, vegetable oils, animal oils, sugars and sugar alcohols, vitamins, organic acids, fruit juice extracts, vegetable extracts, cereals, beans, vegetables, meats, seafood, and other food additives and food ingredients, or may contain two or more of them in combination.

[0073] In addition, if it is a tablet, it can be prepared by mixing the powdered active ingredient with a pharmaceutically permissible carrier component (excipient, etc.) and compressing it. Candy tablets such as candy (maltose) can also be prepared by injecting them into a mold. Sugar coating can also be applied to the tablet to make sugar-coated tablets. In addition, the tablet can be a single-layer tablet or a double-layer tablet or other stacked tablets.

[0074] Granules and other powdered granules can be prepared by various granulation methods (extrusion granulation, crushing granulation, dry compaction granulation, fluidized bed granulation, rolling granulation, high-speed stirring granulation, etc.). Tablets can be prepared by appropriately combining the above-mentioned granulation methods and tableting methods (wet tableting, direct tableting, etc.).

[0075] Capsules can be prepared by conventional methods by filling powdered granules (powder, granules, etc.) into capsules (soft or hard capsules).

[0076] Liquid preparations can be prepared by dissolving or dispersing the components in an aqueous medium (purified water, purified water containing ethanol, etc.) as a carrier component, filtering or sterilizing as needed, filling into a specified container, and sterilizing as per the instructions on page 7 / 10 of CN 122476965 A. Preferred dosage forms for solid preparations are capsules or tablets, more preferably soft capsules (soft capsules, soft capsules).

[0077] Soft capsules have a smooth surface and are easy to swallow, making them popular with users. Examples of common methods for manufacturing soft capsules include flat-plate manufacturing, rotary manufacturing, and seamless manufacturing.

[0078] In rotary manufacturing (punching method), a sheet-like capsule coating clamps the flowing filling contents and forms a capsule shape along the holes of a rotating cylindrical mold. On the other hand, in seamless manufacturing (drop-feed method), the capsule coating composition and contents are simultaneously ejected from multiple concentric nozzles to form a capsule shape without seams.

[0079] There are no particular restrictions on the base agent for the coating of soft capsules.Starch, pullulan, cellulose, polyvinyl alcohol, gelatin, succinylated gelatin, etc., can be used, preferably starch, gelatin, or succinylated gelatin, and more preferably gelatin or succinylated gelatin. These substances can be used alone or in combination of two or more.

[0080] The daily oral intake or dosage of Albizia julibrissin flower, Albizia julibrissin bark, or extract thereof for adults can be appropriately determined based on individual condition, weight, sex, age, activity of the raw material, route of intake or administration, intake or administration plan, formulation form, or other reasons. The daily oral intake or dosage of Albizia julibrissin flower, Albizia julibrissin bark, or extract thereof for adults is preferably 0.1 mg or more, more preferably 1 mg or more, more preferably 10 mg or more, particularly preferably 20 mg or more, and most preferably 30 mg or more. Alternatively, it can be 100 mg or more or 200 mg or more. The preferred daily oral intake or dosage of Albizia julibrissin flower, Albizia julibrissin bark, or their extracts for adults is, for example, less than 2000 mg, more preferably less than 1500 mg, further preferably less than 1000 mg, and particularly preferably less than 500 mg. The preferred daily oral intake or dosage of Albizia julibrissin flower, Albizia julibrissin bark, or their extracts for adults is, for example, 0.1–2000 mg, more preferably 1–1500 mg, further preferably 10–1000 mg, further preferably 20–500 mg, and further preferably 30–500 mg.

[0081] It should be noted that, depending on the dosage form, such as capsules, the daily oral intake or dosage for adults can be divided into 1–6 capsules, 1–4 capsules, 1–3 capsules, or 1–2 capsules for administration.

[0082] The composition of the present invention can be administered once or several times a day, typically once to six times a day, once to three times a day, once to two times a day, or at any time and interval, but preferably once a day.

[0083] Examples

[0084] The present invention will now be specifically described by way of examples, but the present invention is not limited to the following examples.

[0085] [Preparation of the test formulation]

[0086] (Example 1. Ethanol extract 1)

[0087] 30 mL of 99.5% ethanol was added to 3.0 g of dried Albizia julibrissin flower powder, and the mixture was stirred at room temperature for 30 minutes for extraction. Subsequently, the residue was removed by conventional methods, and then dried and solidified to obtain 0.1326 g of dried product.

[0088] (Example 2. Ethanol Extract 2)

[0089] 30 mL of 99.5% ethanol was added to 3.0 g of dried Albizia bark powder, and the mixture was stirred at room temperature for 30 minutes for extraction. Afterwards, the residue was removed using conventional methods, and then the mixture was dried and solidified.Thus, 0.1551g of dried matter was obtained.

[0090] (Example 3. Hot water extract 1)

[0091] 27mL of water was added to 3.0g of dried Albizia julibrissin flower powder, and the mixture was stirred at 90°C for 1 hour for extraction. Subsequently, the residue was removed by conventional methods, and then dried and solidified to obtain 0.7323g of dried matter.

[0092] (Example 4. Hot water extract 2)

[0093] 27mL of water was added to 3.0g of dried Albizia julibrissin bark powder, and the mixture was stirred at 90°C for 1 hour for extraction. Subsequently, the residue was removed by conventional methods, and then dried and solidified to obtain 0.1851g of dried matter.

[0094] (Example 5. Alkaline extract)

[0095] 25 mL of water was added to 3.0 g of dried Albizia julibrissin flower powder, and the pH was adjusted to 9.0 (±0.1) using 0.5 mol / L sodium hydroxide solution. The total amount of water was 33 g. The mixture was stirred at 70 °C for 1 hour for extraction. After adjusting the pH to 7.0 using 0.5 mol / L hydrochloric acid, the residue was removed by conventional methods, and then dried and solidified to obtain 0.5802 g of dried product.

[0096] [Experiment 1. Confirmation test of senescent cell removal ability]

[0097] (1) Preparation of senescent cells

[0098] 10,000 HepG2 cells from human liver cancer were seeded in 12-well plates and treated with 10 μM etoposide (containing 0.1% DMSO) (Sigma-Aldrich) for 2 days to induce cell senescence. To confirm the induction of cell senescence, cells were treated with 1 μM SPiDER-βGal (Dojindo Chemical Research Institute Co., Ltd.), and the fluorescence signal was observed using a GFP filter (excitation wavelength: 470 / 40 nm, absorption wavelength: 525 / 50 nm) on an integrated fluorescence microscope BZ-9000 (Keyence Corporation). The results showed that SPiDER-βGal produced by the β-galactosidase activity of senescent cells was converted into fluorescent substances in cells treated with etoposide.

[0099] (2) Evaluation of senescent cell removal activity

[0100] The ratio of the 50% lethal concentration (LC50) in normal (non-senescent) cells to that in senescent cells was confirmed. LC50 refers to the concentration required to kill half of the cells in the well plate.

[0101] 8000 HepG2 cells were seeded in 96-well plates and treated with 10 μM etoposide (containing 0.1% DMSO) for 2 days to induce cell senescence. Subsequently,The test formulation prepared above was added to RPMI medium (HEPES-free) (Thermo Fisher Scientific) containing 0.179–40 μg / mL of Albizia julibrissin flower and bark extracts. Cells were treated, and cell counts were determined after 2 days using EnVision (PerkinElmer) based on the luminescence intensity measured by CellTiter-Glo (Promega). Based on the measured values ​​of the treatment concentrations, the LC50 was calculated using GraphPad Prism9 (GraphPad Software). The results of the senescent cell removal capacity calculated based on the following formula are shown in Figure 1.

[0102] Method for determining the senescent cell removal capacity

[0103] Senescent cell removal capacity = LC50 in normal (non-senescent) cells / LC50 in senescent cells

[0104] As shown in Figure 1, the senescent cell removal capacity, which is the specific cell death induction capacity of senescent cells, was determined using the above formula. The results showed that the values ​​were 9.8 (hot water extraction), 5.0 (ethanol extraction), and 4.7 (alkali extraction) in Albizia julibrissin flower extract, and 4.2 (hot water extraction) and 3.9 (ethanol extraction) in Albizia julibrissin bark extract. The senescent cell removal capacity of quercetin, which has a known senescent cell removal effect, was investigated under the same conditions, and the result was 1.1. This confirmed that Albizia julibrissin flower extract and Albizia julibrissin bark extract have a higher senescent cell removal capacity than the known quercetin.

[0105] [Experimental Example 2. Motor Function Confirmation Test]

[0106] (1) Fruit fly rearing

[0107] Wild-type fruit flies (W1118 system) were used in the experiment. Male fruit flies that have emerged from their molts were raised in an environment with a temperature of 25±3℃, humidity of 70±20%, and a 12-hour light-dark cycle. For the control group, conventional bait (corn flour 4.4 w / w%, dry yeast Y4 5 w / w%, powdered agar 0.44 w / w%, glucose 5.6 w / w%, propionic acid 0.44 w / w%, bokinin (preservative) 0.41 w / w%) was placed at the bottom of a bottle (22 mm in diameter, 96 mm in height) to allow fruit flies to feed freely; for the Albizia julibrissin flower extract group (0.1 mg / mL), bait prepared by adding Albizia julibrissin flower extract at a final concentration of 0.1 mg / mL using the same method as in Example 3. Hot water extract 1, page 9 / 10, CN 122476965 A, was placed at the bottom of a bottle to allow fruit flies to feed freely; for the Albizia julibrissin bark extract group (0.01 mg / mL), bait prepared by adding Albizia julibrissin bark extract at a final concentration of 0.01 mg / mL using the same method as in Example 4. Hot water extract 2, was placed at the bottom of a bottle (22 mm in diameter, 96 mm in height).The bottom of the bottle (96 mm high) was left open to allow the fruit flies to feed freely; once a week, the fruit flies were moved to a bottle containing fresh food.

[0108] (2) Evaluation of motor function

[0109] The motor function of the fruit flies was evaluated by performing a climbing assay and assessing negative geotropism. The climbing assay was performed under the following conditions. Ten fruit flies were moved to an empty bottle without food. After the bottle was tapped to make the fruit flies fall to the bottom, the fruit flies were filmed climbing the bottle wall. Ten seconds after the fruit flies fell to the bottom, the number of fruit flies in the upper 1 / 3, middle 1 / 3 and lower 1 / 3 of the bottle was counted. For each fruit fly, the fruit flies in the upper part of the bottle were scored as 3 points, the fruit flies in the middle part as 2 points and the fruit flies in the lower part as 1 point. The total score of each group was calculated by dividing the total score by the number of fruit flies. The average climbing score was calculated by dividing the total score by the number of fruit flies. The results obtained by calculating the average climbing score for each age are shown in Table 1, Table 2, Figure 2, and Figure 3, respectively.

[0110] (3) Evaluation of the improvement of motor function by Albizia julibrissin extract

[0111] [Table 1]

[0112] As shown in Table 1 and Figure 2, the average climbing score representing the motor ability of fruit flies was calculated. The result was that in the Albizia julibrissin extract group, the score was 1.94 at 36 days of age. In the control group, the score was 1.49 under the same age conditions, thus confirming that Albizia julibrissin extract has the ability to inhibit the decline of motor function.

[0113] (4) Evaluation of the improvement of motor function by Albizia julibrissin bark extract

[0114] [Table 2]

[0115] As shown in Table 2 and Figure 3, the average climbing score representing the motor ability of fruit flies was calculated. The result was that in the Albizia julibrissin bark extract group, the score was 2.04 at 36 days of age. In the control group, the score was 1.23 under the same age conditions.This confirms that the extract of Albizia julibrissin bark has the ability to inhibit the decline in motor function. (Instruction manual 10 / 10 pages 12 CN 122476965 A Figure 1 Figure 2 Instruction manual Figures 1 / 2 pages 13 CN 122476965 A Figure 3 Instruction manual Figures 2 / 2 pages 14 CN 122476965 A Abstract The purpose of the present invention is to provide a preparation and a composition that are effective in removing senescent cells and can be ingested even in the field of food and beverage products. Provided is an agent for removing senescent cells, the agent containing an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts of these.)

Claims

1. A cell-removing agent, wherein, The senescent cell remover contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof.

2. The senescent cell removal agent according to claim 1, wherein, The senescent cell removal agent is labeled with at least one of the following: "reducing senescent cells", "removing senescent cells", "reducing the proportion of senescent cells", "promoting the reduction of senescent cells", and "inhibiting the decline in motor function".

3. The senescent cell removal agent according to claim 1, characterized in that, The removal of senescent cells refers to the selective removal of senescent cells relative to normal cells.

4. The senescent cell removal agent according to claim 1, characterized in that, The ratio of the 50% lethal concentration (LC50) A in normal cells to the 50% lethal concentration B in senescent cells (A / B) exceeds 1.

1.

5. The senescent cell removal agent according to claim 1, wherein, The senescent cell remover is a food, cosmetic, or pharmaceutical product.

6. A motor function reduction inhibitor, wherein the motor function reduction inhibitor contains an effective amount of at least one selected from the group consisting of Albizia julibrissin flowers, Albizia julibrissin bark, and extracts thereof.